Cargando…
Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice
BACKGROUND: Ginsenoside Rg1 (Rg1), an active ingredient in ginseng, may be a potential agent for the treatment of Alzheimer’s disease (AD). However, the protective effect of Rg1 on neurodegeneration in AD and its mechanism of action are still incompletely understood. METHODS: Wild type (WT) and APP/...
Autores principales: | Zhang, Han, Su, Yong, Sun, Zhenghao, Chen, Ming, Han, Yuli, Li, Yan, Dong, Xianan, Ding, Shixin, Fang, Zhirui, Li, Weiping, Li, Weizu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569324/ https://www.ncbi.nlm.nih.gov/pubmed/34764721 http://dx.doi.org/10.1016/j.jgr.2021.03.003 |
Ejemplares similares
-
Ginsenoside Rg1 alleviates lipopolysaccharide-induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells
por: Zhang, Yaodong, et al.
Publicado: (2021) -
Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice
por: Li, Yan, et al.
Publicado: (2021) -
Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice
por: Li, Xuewang, et al.
Publicado: (2023) -
Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury due to inhibition of NOX2-mediated calcium homeostasis dysregulation in mice
por: Han, Yuli, et al.
Publicado: (2022) -
Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice
por: Li, Xuewang, et al.
Publicado: (2022)